Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10976 - 11000 of 11918 in total
Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative bacterial infections.
Investigational
Matched Description: … Garenoxacin, a quinolone antibiotic, is being investigated for the treatment of gram-positive and gram-negative …
Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
Investigational
Matched Description: … It is a dichloro-derivative of chloroguanide. …
Hispidulin (4',5,7-trihydroxy-6-methoxyflavone) is a potent benzodiazepine (BZD) receptor ligand with positive allosteric properties .
Experimental
Matched Description: … Hispidulin (4',5,7-trihydroxy-6-methoxyflavone) is a potent benzodiazepine (BZD) receptor ligand with …
TOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia gravis.
Investigational
Matched Description: … TOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia …
INT41 (also known as rAAV6-INT41) is a recombinant adeno-associated virus vector containing DNA encoding INT41 intrabody.
Investigational
Matched Description: … INT41 (also known as rAAV6-INT41) is a recombinant adeno-associated virus vector containing DNA encoding …
GMI-1359 is a small molecule, glycomimetic compound with dual inhibitory activity against E-selectin and CXCR4.
Investigational
Matched Description: … GMI-1359 is a small molecule, glycomimetic compound with dual inhibitory activity against E-selectin …
MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational
Matched Description: … MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed …
C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV) internal repeat short 1 (IRS1).
Investigational
Matched Description: … C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV …
SLN500 is a synthetic double-strand small interfering ribonucleic acid (siRNA) oligonucleotide drug directed against C3 messenger RNA
Investigational
Matched Description: … SLN500 is a synthetic double-strand small interfering ribonucleic acid (siRNA) oligonucleotide drug directed …
TST10088 is a recombinant variant of a plant toxin belonging to the family of class II ribosome inactivating proteins. These molecules efficiently kill cells by activating preprogrammed death pathways known as apoptosis. TST10088 has been designed and engineered by Twinstrand to contain a peptide switch that is specifically cleaved by...
Investigational
Matched Description: … TST10088 is a recombinant variant of a plant toxin belonging to the family of class II ribosome inactivating ... TST10088 has been designed and engineered by Twinstrand to contain a peptide switch that is specifically …
VB2-011 is an antibody developed as an anti-cancer treatment. According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers including lymphoma and melanoma. This drug includes the parent IgM (H11 IgM) and a recombinant IgG version (H11 IgG).
Investigational
Matched Description: … This drug includes the parent IgM (H11 IgM) and a recombinant IgG version (H11 IgG). ... According to some preclinical studies, it has a potential to inhibit tumour growth in various cancers …
Subasumstat is under investigation in clinical trial NCT03648372 (A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)).
Investigational
Matched Description: … Subasumstat is under investigation in clinical trial NCT03648372 (A Study to Evaluate the Safety, Tolerability ... Participants With Advanced or Metastatic Solid Tumors or Relapsed/refractory Hematologic Malignancies and in a
JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase.
Experimental
Matched Description: … JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase. …
Kebuzone (also known as ketophenylbutazone ) is a non-steroidal anti-inflammatory drug.
Experimental
Matched Description: … Kebuzone (also known as ketophenylbutazone ) is a non-steroidal anti-inflammatory drug. …
Cloperastine is a cough suppressant that acts on the central nervous system.
Experimental
Matched Description: … Cloperastine is a cough suppressant that acts on the central nervous system. …
Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects.
Investigational
Matched Description: … Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects. …
KT-333 is a small molecule targeted protein degrader of STAT3.
Investigational
Matched Description: … KT-333 is a small molecule targeted protein degrader of STAT3.[L44086] …
MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.
Investigational
Matched Description: … MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.[L48161] …
rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase.
Investigational
Matched Description: … rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase. …
ZVS101e is a recombinant adeno-associated virus vector carrying human CYP4V2 gene.
Investigational
Matched Description: … ZVS101e is a recombinant adeno-associated virus vector carrying human CYP4V2 gene. …
EI-1071 is a selective Colony Stimulating Factor-1 Receptor kinase inhibitor.
Investigational
Matched Description: … EI-1071 is a selective Colony Stimulating Factor-1 Receptor kinase inhibitor. …
SD118 was previously under investigation in Japan for a different indication and now, following re-profiling and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for neuropathic pain.
Investigational
Matched Description: … SD118 was previously under investigation in Japan for a different indication and now, following re-profiling ... and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for …
MW33 is a recombinant fully human antibody to SARS-CoV-2. This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection).
Investigational
Matched Description: … MW33 is a recombinant fully human antibody to SARS-CoV-2. ... antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A
Displaying drugs 10976 - 11000 of 11918 in total